Skip to content

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer

The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer Operation: Prospective Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02920554
Enrollment
88
Registered
2016-09-30
Start date
2014-07-31
Completion date
2030-12-31
Last updated
2024-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder Cancer

Keywords

gallbladder cancer, bisegmentectomy

Brief summary

The extent of hepatic resection for gallbladder cancer can be done from a wedge resection to 4b/5 bisegmentectomy. This study aims to compare the recurrence rates and survival rates between wedge resection group and bisegmentectomy group. Patients with T2 or T3 gallbladder cancer on preoperative CT exam or patients who were pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy were enrolled. All patients are randomly assigned to wedge resection or bisegmentectomy group. Number of patients in each group is 44. Primary endpoint is recurrence-free-survival rates and overall survival rates.

Detailed description

The extent of hepatic resection for gallbladder cancer has a wide range. A partial hepatectomy involving the gallbladder fossa is a critical part of the resection but can range from a wedge resection to an anatomic resection of segments 4b and 5 to an extended right hepatectomy. This study enrolls Patients with T2 or T3 gallbladder cancer on preoperative CT exam or patients who were pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy. Eighty eight patients are randomized to wedge resection group or bisegmentectomy group. Except the extent of hepatic resection, all the procedures including hepatoduodenal,common hepatic, posterior pancreatic lymph node dissection are same. Primary endpoint is recurrence-free-survival rates and overall survival rates.

Interventions

The extent of hepatic resection is wedge resection of liver including gallbladder fossa

PROCEDUREbisegmentectomy

The extent of hepatic resection is 4b/5 bisegmentectomy of liver

Sponsors

Saint Vincent's Hospital, Korea
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with T2 or T3 gallbladder cancer on preoperative CT exam * Patients who are pathologically diagnosed as T2 or T3 gallbladder cancer after initial simple cholecystectomy

Exclusion criteria

* Peritoneal seeding or distant metastasis * Impossible to resect the cancer radically * Pathologically diagnosed to other malignancy such as adenosquamous carcinoma, sarcoma, etc. * R1 or R2 resection were pathologically diagnosed.

Design outcomes

Primary

MeasureTime frameDescription
Survival rates1 year3year 5 year

Countries

South Korea

Contacts

Primary ContactDong Do You, MD, PhD
tzanggu@catholic.ac.kr82-31-249-8303
Backup ContactKwang Yeol Paik, MD, PhD
kpaik@catholic.ac.kr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026